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Abstract
Chemicals that activate nuclear factor-E2-related factor-2 (Nrf2) often increase multidrug
resistance-associated protein expression in liver. Hepatocyte-specific deletion of Kelch-like ECH-
associated protein 1 (Keap1) activates Nrf2. Use of hepatocyte-specific Keap1 deletion represents
a non-pharmacological method to determine whether constitutive Nrf2 activation upregulates liver
transporter expression in vivo. The mRNA, protein expression and localization of several
biotransformation and transporters was determined in livers of wild-type and hepatocyte-specific
Keap1-null mice. Sulfotransferase 2a1/2, NADP(H):quinone oxidoreductase 1, Cytochrome P450
2b10, 3a11, and glutamate-cysteine ligase catalytic subunit expression was increased in livers of
Keap1-null mice. Oatp1a1 expression was nearly abolished, as compared to that detected in livers
of wild-type mice. By contrast, Mrp 1-5 mRNA and protein levels were increased in Keap1-null
mouse livers, with Mrp4 expression being more than 15-fold higher than wild-types. In summary,
Nrf2 has a significant role in affecting expression of Oatp and Mrp expression.
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Keap1; Nrf2; nfe2l2; Organic anion transporting polypeptide (Oatp); Multidrug resistance-
associated protein (Mrp); Abcc4
Introduction
The nuclear factor-E2-related factor-2 (Nrf2; nfe2l2) transcription factor coordinately
regulates gene expression of antioxidant and phase-II drug metabolizing enzymes (DMEs)
by binding to antioxidant/electrophile responsive elements (ARE/EpRE) found in the
promoters of target genes [1-3]. The cytoplasmic protein Keap1 suppresses Nrf2
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transcriptional activity under basal conditions through direct binding to Nrf2 and promoting
proteasomal degradation [4-6]. In cells under stress, Nrf2 dissociates from Keap1 leading to
decreased Nrf2 degradation. As a result, Nrf2 accumulates in the nucleus and recruits to the
ARE/EpRE, where it initiates transcription of target genes. Mice with hepatocyte-specific
deletion of Keap1 have constitutive nuclear accumulation of Nrf2 and activation of ARE-
dependent gene transcription [7]. In this study, hepatocyte-specific Keap1-null mice were
generated because whole-body Keap1-deletion results in severe growth retardation and
lethality by approximately three weeks [7].
Antioxidants and DMEs are important for protecting cells against oxidative stress, and play
a central role to the detoxification of xenobiotics. High expression of Nrf2-dependent
antioxidant stress genes and DMEs in hepatocyte-specific Keap1-null mutant mice confer
potent resistance to drug toxicity [7]. However, hepatobiliary transporters, which mediate
hepatic uptake and efflux processes, also act to prevent tissue injury through enhanced
efflux activity. Recent studies demonstrate that Nrf2 regulates gene expression of
transporters including Multidrug resistance-associated proteins (Mrp) 1-4 [8-10], in addition
to phase-II enzymes and DMEs. Therefore, constitutive Nrf2 activation may influence
expression of hepatobiliary transporters in mice with hepatocyte-specific deletion of Keap1,
which in turn could contribute to altered chemical disposition in liver and increased
resistance to chemical-induced hepatotoxicity.
Hepatic uptake transporters are localized to the basolateral membrane and transport
xenobiotics and bile acids into hepatocytes. They include organic anion-transporting
polypeptides (Oatps) (mainly Oatp1a1, 1a4, and 1b2), sodium/taurocholate-cotransporting
polypeptide (Ntcp), and organic cation transporters. Efflux transporters are localized to both
the basolateral and canalicular membranes. Basolateral efflux transporters, including Mrp 1,
3-6, mediate efflux of chemicals from hepatocytes into blood. The canalicular efflux
transporters Mrp2, multidrug resistance proteins (Mdrs), bile salt export pump (Bsep), and
breast cancer resistance protein (Bcrp) mediate excretion of multiple chemicals and their
metabolites from hepatocytes into bile. In the current study we determined the mRNA and
protein expression of several DMEs and transporters in livers of wild-type and hepatocyte-
specific Keap1-null mice. The results indicate that constitutive activation of Nrf2 alters gene
and protein expression of hepatic uptake and efflux transporters as well as drug metabolizing
enzymes, and thus Nrf2 likely plays a large role in cellular resistance to toxic chemicals by
affecting xenobiotic disposition.
Materials and Methods
Animals
Mice with hepatocyte-specific deletion of Keap1 gene (Alb-Cre∷Keap1flox/−) were
generated by Dr. Yamamoto's research group and the generation method was previously
described [7]. Corresponding wild-type controls were Keap1+/+ mice Livers were harvested
from mice at age of 9-13 week, snap frozen with liquid nitrogen, and stored in −80°C for
future analysis.
RNA Extraction
Total RNA from liver was extracted using the RNA Bee reagent (Tel-Test Inc.,
Friendswood, TX) according to the manufacturer's protocol. RNA integrity was confirmed
by formaldehyde-agarose gel electrophoresis and concentration was determined by UV
absorbance at 260 nm.
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Branched DNA Signal Amplification (bDNA) Assay
Probe sets for mouse Cyp4a14, 2b10, 3a11, 2e1, Ho-1, Nqo1, Sult2a1/2, Mrp1-6, Oatp1a1,
1a4, 1b2, 1a6, 2b1, Bsep, Bcrp, Ntcp, and Mdr2 have been described previously [11-17].
The method for the bDNA assay has been described in detail previously [18].
Membrane, Cytosol, and Nuclear Fraction Preparation
Livers (∼50 mg) were homogenized in sucrose-Tris (ST) buffer (10 × volume of sample
amount, 0.25 mol/L sucrose, 10 mmol/L Tris–HCl, pH 7.4) containing protease inhibitor
cocktail (2 μL/mL, Sigma Chemical Co. P8340) and centrifuged at 100,000 × g for 60 min
at 4°C. The resulting supernatant was the cytosolic fraction and the pellet contained the
membrane fraction. ST buffer was used to resuspend the resulting pellet (membrane
fraction). Nuclear proteins were prepared from liver using the NE-PER kit (Pierce,
Rockford, IL) according to the manufacturer's instructions. Membrane, cytosolic, and
nuclear protein concentrations were determined by the method of Lowry using Bio-Rad
protein assay reagents (Bio-Rad Laboratories, Hercules, CA). Equal protein loading for
SDS-PAGE was confirmed by Coomassie Brilliant Blue staining.
Western Analysis of Mouse Liver Fractions
Methods for western blot analysis of transport and enzyme proteins were according to
previous reports [18]. Detailed methods for detecting Oatp, Mrp, and Nrf2 protein levels
have been previously described [18]. β-actin was used as a loading control and measured as
a housekeeping gene. Proteins (50 μg of protein/lane) were electrophoretically resolved
using polyacrylamide gels (8, 10, or 12% resolving, 4% stacking) and transblotted overnight
at 4°C onto PVDF membrane (Millipore, Bedford, MA). The membranes were blocked with
2% nonfat dry milk in PBS with 0.1% Tween (PBS/T) for 1 h and then incubated for 2 h
with the primary antibody diluted in blocking buffer (PBS/T with 2% milk) at room
temperature. After washing, the membranes were incubated for 1 h with a species-
appropriate peroxidase-labeled secondary antibody (Sigma-Aldrich, St. Louis, MO) diluted
in 2% milk-PBS/T at room temperature. After incubation with the secondary antibody,
membranes were washed with PBS, incubated with ECL chemiluminescent kit (Amersham
Life Science, Arlington Heights, IL), and exposed to Fuji medical X-ray film (Fisher
Scientific, Springfield, NJ). The intensity of the protein bands was quantified using Kodak
Molecular Imaging Software (Vision 4.0.4, Eastman Kodak Company).The intensity of the
protein bands was quantified using Image J 1.38× software download from National Institute
of Health, USA (http://rsb.info.nih.gov/ij/). Background was subtracted before
quantification. Mrp4 protein expression could not be quantified because Mrp4 protein was
not detected in liver fractions of wild-type mice.
Immunofluorescent Staining and Epifluorescent Microscopy
Frozen mouse livers were embedded in optimal cutting temperature compound and brought
to −20°C. Cryosections (5 μm) were thaw-mounted onto Superfrost glass slides (Fisher
Scientific) and stored at −80°C under dehumidified conditions until use. Tissue sections
were fixed with 4% paraformaldehyde for 5 min. Sections were blocked with 5% goat or
donkey serum/phosphate-buffered saline (PBS) with 0.1% Triton X-100 for 1 hr and then
incubated with BXP-53 (Bcrp), Mrp2, M3II-2 (Mrp3) or M4I-10 primary antibodies
(donated from Drs. George Scheffer and Bruno Steiger, VU Medical Center, The
Netherlands) diluted 1:100 in 5% goat serum/PBS with Triton X-100 for 2 hrs at room
temperature. All antibody solutions were filtered through 0.22 μm membrane syringe-driven
filter units (Osmonics Inc., Minnetonka, MN) prior to use. After incubation with primary
antibody, the sections were washed three times in PBS with Triton X-100 and incubated for
1 hr with either goat anti-rat or donkey anti-rabbit IgG AlexaFluor 488 IgG (Invitrogen
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Corporation, Carlsbad, California) diluted 1:200 in 5% goat serum/ PBS with Triton X-100.
Slides were washed in PBS and then rinsed twice in distilled deionized water. Sections were
air dried and mounted in Prolong Gold with DAPI (Invitrogen Corp.). Sections were
visualized and images were captured using a Zeiss Axiocam Epifluorescent Microscope at
an excitation wavelength of 409 and 488 nm with AxioVision LE Rel.4.5. Negative control
staining was performed by incubating cryosections without primary antibody (data not
shown).
Statistical Analysis
Statistical analyses of differences were performed by Student's t test. P < 0.05 was
considered statistically significant. Unless otherwise stated, all data were presented as mean
± SE of five animals.
Results
Liver Expression of Drug Metabolizing and Antioxidant Enzymes in Hepatocyte-Specific
Keap1-null Mice
mRNA expression of antioxidant stress and drug metabolizing enzymes is illustrated in
Figure 1(A). Hepatocyte-specific deletion of Keap1 decreased mRNA expression of
Cyp4a14 and 3a11 in mouse livers to 20% and 80% of wild type mice, respectively.
Cyp2b10, 2e1, Nqo1, and Sult2a1/2 mRNA was induced in livers of hepatocyte-specific
Keap1-null mice, by 17.0, 1.4, 6.0, and 16.0-fold, respectively, compared to wild-types.
Hepatic Ho-1 mRNA expression was similar between knockout and wild type mice. Western
blotting showed that Cyp3a11, Nqo1, Gclc, and Nrf2 protein expression in livers was
significantly increased in hepatocyte-specific Keap1-null mice, being 2.6-, 16.0-, 2.3-, and
2.1-fold of that detected in livers of wild type mice, respectively (Figure 1(B) and (C)).
Hepatic Cyp2e1 and Ho-1 protein levels in knockout mice were not significantly different
from wild types. Cyp4a14, 2b10, and Sult2a1/2 protein expression was not analyzed. β-actin
protein expression in cytosolic and membrane fractions did not differ between wild types
and Keap1-null mice.
Liver Expression of Uptake Transporters in Hepatocyte-Specific Keap1-null Mice
As shown in Figure 2(A), hepatic Oatp1b2 mRNA expression was increased 1.3-fold
hepatocyte-specific Keap1-null mice compared to wild type mice. Expression of Oatp1a1,
1a4, 2b1, and Ntcp mRNA was not significantly different between hepatocyte-specific
Keap1-null mice and wild types, while Oatp1a1 mRNA expression in knockout mice was
70% that in wild types. Figures 2(B) and (C) show protein expression of hepatic uptake
transporters in wild-type and hepatocyte-specific Keap1-null mice. Consistent with its
mRNA expression level, Oatp1b2 protein expression was induced 2.0-fold in livers from
hepatocyte-specific Keap1-null mice. In contrast to its high hepatic expression in wild-type
mice, Oatp1a1 protein expression was almost completely abolished in hepatocyte-specific
Keap1-null mice; levels of Oatp1a1 protein in knockout mice were only 15% of wild types.
Deletion of Keap1 decreased Ntcp protein expression to 53% of wild types. No difference in
Oatp1a4 protein expression was observed between genotypes.
Liver Expression of Efflux Transporters in Hepatocyte-Specific Keap1-null Mice
Basolateral efflux transporter Mrp3, 4, and 5 mRNA were elevated in livers of hepatocyte-
specific Keap1-null mice as compared to wild types, with 2.2, 15.1, and 12.0-fold increases,
respectively (Figure 3(A)). Hepatic Mrp1 mRNA in hepatocyte-specific Keap1-null mice
was decreased to 36% of wild types, and Mrp6 mRNA expression in livers was similar
between genotypes. As illustrated in Figures 3 (B) and (C), the basolateral efflux
Cheng et al. Page 4
J Biochem Mol Toxicol. Author manuscript; available in PMC 2013 July 14.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
transporters, namely Mrp1, 3, 4, and 5, display induced protein expression in livers of
hepatocyte-specific Keap1-null mice. Western blotting assay did not detect Mrp4 protein in
livers of wild type mice, whereas marked expression was observed in hepatocyte-specific
Keap1-null mice. Quantification of the western blots showed that Mrp1, 3, and 5 protein
expression was 1.4-, 3.3- and 2.0-fold higher, respectively, in livers of the knockout mice
compared to wild types.
Liver mRNA expression of canalicular efflux transporters is shown in Figure 4(A). Mrp2
and Bcrp mRNA were increased approximately 1.5-fold in hepatocyte-specific Keap1-null
mice, comparing to wild types, whereas Mdr2 and Bsep mRNA levels were similar between
genotypes. Mrp2 protein was 2.6-fold higher in livers from hepatocyte-specific Keap1-null
mice compared to wild types, whereas no difference in Bcrp protein was observed (Figures
4(B) and (C)).
Localization of Efflux transporters in Livers of Hepatocyte-Specific Keap1-null Mice
Immunohistochemical staining was performed on frozen liver sections from wild-type and
hepatocyte specific null-mice. Canalicular Bcrp and Mrp2 staining was punctuate and
branch-like in both genotypes (Figure 5). The intensity of Bcrp and Mrp2 staining was
higher in liver sections from Keap1-null mice. Mrp3 staining was basolateral, and
significantly higher in both centrilobular and periportal regions of livers of Keap1-null mice.
Basal Mrp4 staining was barely detectable in liver sections from wild-type mice, whereas
Mrp4 staining was markedly increased in livers of Keap1-null mice (Figure 5). Specifically,
Mrp4 protein was upregulated in centrilobular hepatocytes and bile-duct epithelial cells in
mice with a hepatocyte-specific deletion of Keap1.
Discussion
Deletion of the Keap1 gene results in disruption between Keap1 and Nrf2 resulting in
constitutive Nrf2 activation [7]. As expected, Nqo1 expression was increased in livers
Keap1-null mice compared to wild types. Additionally, Keap1 deletion increased liver
Cyp2b10, 3a11, and Sult2a1/2 mRNA and/or protein expression. Increased enzyme
expression in hepatocyte-specific Keap1-null mice suggests that Nrf2 has a role in Cyp2b10,
3a11, and Sult2a1/2 up-regulation. Studies have demonstrated that many metabolizing
enzymes are regulated by several transcription factors. First, Cyp3a is up-regulated via
Pregnane-x-receptor (PXR), Constitutive Androstane Receptor (CAR), the glucocorticoid
receptor (GR), or Nrf2 activation [15; 20; 21]. Second, Aryl hydrocarbon receptor (AhR)
activation can cause Nrf2 activation [22] – via Nrf2 as a target gene of the AhR, indirectly
via oxidative stress from Cyp1a1-generated reactive oxygen species, or direct cross-
interaction of AhR/XRE (xenobiotic response elements). Nrf2 also regulates AhR
expression and subsequently modulates AhR-target genes expression (e.g. Cyp1a1 and 1b1)
[23]. Third, crosstalk between CAR and Nrf2 transcriptional pathways likely exists because
compounds that activate the ARE/EpRE also activate CAR [24; 25].
Oatp1a1 and Ntcp mRNA expression was not significantly changed in Keap1-null mice,
whereas Oatp1b2 was induced. In contrast, Oatp1a1 and Ntcp protein expression was
decreased. Oatp1a1 is often down-regulated by microsomal enzyme inducers (MEIs) such as
AhR and PXR ligands, as well as, CAR peroxisome proliferator-activated receptor α
(PPARα), and Nrf2 activators [15]. Oatp1b2 mRNA expression is not affected by treatment
with typical MEIs [15]. However, Oatp1b2 mRNA and protein expression was elevated in
livers of hepatocyte-specific Keap1-null mice.
In the current study, Mrp transporters (Mrp1-5) were increased by hepatocyte-specific
Keap1 deletion. Nrf2 activating compounds, such as butylated hydroxyanisole, oltipraz, and
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ethoxyquin increase Mrp expression [26]. Nrf2 regulates constitutive and inducible mRNA
and protein expression of mouse Mrp1 in embryo fibroblasts [9]. An ARE-like sequence is
present in the Mrp2 promoter [27], Nrf2 binds to AREs in the promoter regions of mouse
Mrp2, and activation of the Nrf2, caused by hepatocyte-specific deletion of GCLC or Nrf2
activators, stimulates induction of hepatic Mrp2-4 [8]. In addition to Nrf2, other nuclear
receptors may also be involved in regulation of Mrps expression including AhR (for Mrp2,
3, 5, and 6), CAR (for Mrp2-6), PXR and PPARα (for Mrp3) [26; 28-30]. Data in the
present study illustrate that Mrp2-4 and Bcrp expression are increased with Keap1 deletion,
which are consistent with previous findings in Keap1 knockdown mice [31].
The expression of several gene targets was differentially regulated at the mRNA and protein
level – namely Cyp3a11, Cyp2e1, Oatp1a1, and Ntcp. The discordance between mRNA and
protein levels indicate that the role for Keap1 in modulating DME and transporter protein
expression is complex and could occurs through affecting pathways that modulate post-
translational processes, such as proteasomal degradation via ubiquitination. It is known that
Nrf2 activity is regulated through the modulation of the Cullin3 (Cul3)-containing E3-ligase
complex [32], but it is not well described about how Nrf2 activity affects the levels of other
proteins through indirect or non-transcriptional mechanisms.
Hepatobiliary transporter expression was increased livers of hepatocyte specific Keap1-null
mice, with Mrp4 mRNA expression in livers of Keap1-null mice being more than 15-fold
higher than wild-type mice and is consistent with previous findings [31, 33]. The data
presented demonstrate a non-pharmacological induction of Multidrug resistance-associated
proteins via modulation of the Keap1-Nrf2 pathway.
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Figure 1.
Drug metabolizing and antioxidant enzyme Cytochrome P450 (Cyp) 4a14, 2b10, 3a11, 2e1,
NAD(P)H:quinone oxidoreductase 1 (Nqo1), Sulfotransferase (Sult) 2a1/2, Heme
oxygenase-1 (Ho-1), and nuclear factor-E2-related factor-2 (Nrf2) mRNA and protein
expression in livers of wild-type (WT) and hepatocyte-specific Keap1-null (KO) mice. (A).
Western blot of Nrf2 proteins in nuclear fractions isolated from livers from WT and KO
mice (protein loading amount 50 μg/lane, n = 4). (B) Cyp4a14, 2b10, 3a11, 2e1, Nqo1,
Sult2a1/2, and Ho-1 mRNA expression. Total RNA was isolated from liver and mRNA
levels were quantified using branched DNA signal amplification assay. mRNA expression
level is presented as mean RLU ± SEM (n = 4 animals). Asterisks (*) represent a statistical
difference between WT and KO (p < 0.05). (c). Western blots of Cyp3a11, 2e1, Nqo1, Ho-1,
Gclc, and membrane fraction B-actin [β-actin(m)] and cytosolic B-actin [β-actin(c)] protein
expression in liver fractions from WT and KO mice (protein loading amount 50 μg/lane, n =
4). (C). Quantification of Cyp3a11, 2e1, Nqo1, Ho-1, Gclc, and Nrf2 relative protein
expressions in KO mice compared to WT. Asterisks (*) represent a statistical difference
from corresponding WT (p < 0.05).
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Figure 2.
Organic anion transporting polypeptide (Oatp) 1a1, 1a4, 1b2, 2b1, and sodium/taurocholate
cotransporting polypeptide (Ntcp) mRNA and protein expression in livers of wild-type (WT)
and hepatocyte-specific Keap1-null (KO) mice. (A). mRNA expression of Oatp1a1, 1a4,
1b2, 2b1, and Ntcp. Total RNA was isolated from liver and mRNA levels were quantified
using branched DNA signal amplification assay. mRNA expression level is presented as
mean RLU ± SEM (n = 4 animals). Asterisks (*) represent a statistical difference between
WT and KO (p < 0.05). (B). Individual Western blots of Oatp1a1, 1a4, 1b2, and Ntcp in
livers from WT and KO mice (protein loading amount 50 μg/lane, n = 4). (C).
Quantification of Oatp1a1, 1a4, 1b2, and Ntcp relative protein expressions in KO mice
compared to WT. Asterisks (*) represent a statistical difference from corresponding WT (p
< 0.05).
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Figure 3.
Multidrug resistance-associated protein (Mrp) 1, 3-6 mRNA and protein expression in livers
of wild-type (WT) and hepatocyte-specific Keap1-null (KO) mice. (A). mRNA expression
of Mrp1, 3-6. Total RNA was isolated from liver and mRNA levels were quantified using
branched DNA signal amplification assay. mRNA expression level is presented as mean
RLU ± SEM (n = 4 animals). Asterisks (*) represent a statistical difference between WT and
KO (p < 0.05). (B). Individual Western blots of Mrp1, 3, 4, and 5 in livers from WT and KO
mice (protein loading amount 50 μg/lane, n = 4). (C). Quantification of Mrp1, 3, and 5
relative protein expressions in KO mice compared to WT. No quantification for Mrp4
because it is undetectable in WT livers. Asterisks (*) represent a statistical difference from
corresponding WT (p < 0.05).
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Figure 4.
Multidrug resistance-associated protein 2 (Mrp2), Multidrug resistance protein 2 (Mdr2),
bile salt export pump (Bsep), breast cancer resistance protein (Bcrp) mRNA and protein
expression in livers of wild-type (WT) and hepatocyte-specific Keap1-null (KO) mice. (A).
mRNA expression of Mrp2, Mdr2, Bsep, and Bcrp. Total RNA was isolated from liver and
mRNA levels were quantified using branched DNA signal amplification assay. mRNA
expression level is presented as mean RLU ± SEM (n = 4 animals). Asterisks (*) represent a
statistical difference between WT and KO (p < 0.05). (B). Individual Western blots of Bcrp
and Mrp2 in livers from WT and KO mice (protein loading amount 50 μg/lane, n = 4). (C).
Quantification of Bcrp and Mrp2 relative protein expressions in KO mice compared to WT.
Asterisks (*) represent a statistical difference from corresponding WT (p < 0.05).
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Figure 5.
Immunofluorescent detection of Bcrp, Mrp2-4 in livers of wild-type and hepatocyte-specific
Keap1-null (Keap1-null) mice. (A) Representative photomicrographs depict fluorescent
immunohistochemical localization of Bcrp, Mrp2, and Mrp3 in liver. Cryosections (4-5 μm)
of livers from WT and Keap1-null mice were stained with BXP-53 (Bcrp), Mrp2, M3II-2
(Mrp3), and M4I-10 antibodies followed by incubation with goat or donkey anti-rat or –
rabbit IgG AlexaFluor 488 IgG. Photomicrographs of Bcrp and Mrp2 staining in canaliculi,
and Mrp3 staining in the basolateral membrane are shown. (Original magnification ×200).
(B) Representative photomicrographs depict fluorescent immunohistochemical localization
of Mrp4 in liver. Mrp4 staining was upregulated in hepatocytes surrounding the central vein
(left panel) and bile-duct epithelia (right panel) (Original magnifications ×100, 400, 630).
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